LENZ Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
LENZ
CUSIP
52635N103
Type
Equity
Class
COM
Num filings
68
Total reported value, excl. options
$328 M
Manager Report Date Value ($000) Shares Option Type